Qin He

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Zhirong Zhang · 6 shared papers, 2019–2022 · strength 0.74
   • Paper Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradig… DOI 10.1016/j.actbio.2022.03.050↗
   • Paper Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immu… DOI 10.1016/j.ejpb.2021.05.014↗
   • Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
2. Man Li · 5 shared papers, 2019–2021 · strength 0.56
   • Paper Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immu… DOI 10.1016/j.ejpb.2021.05.014↗
   • Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
   • Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗
3. Qianwen Yu · 2 shared papers, 2020–2021 · strength 0.22
   • Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
   • Paper Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated … DOI 10.1016/j.jconrel.2020.02.011↗
4. Miao Deng · 2 shared papers, 2019–2021 · strength 0.20
   • Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗
   • Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019↗
5. Xiaoxiao Chen · 2 shared papers, 2019–2021 · strength 0.20
   • Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗
   • Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019↗
6. Rongping Zhang · 1 shared paper, 2022 · strength 0.17
   • Paper Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradig… DOI 10.1016/j.actbio.2022.03.050↗
7. Ting Zhao · 1 shared paper, 2022 · strength 0.17
   • Paper Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradig… DOI 10.1016/j.actbio.2022.03.050↗
8. Zhengze Lu · 1 shared paper, 2021 · strength 0.14
   • Paper Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immu… DOI 10.1016/j.ejpb.2021.05.014↗
9. Jiao He · 1 shared paper, 2021 · strength 0.12
   • Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
10. Qinglin Sheng · 1 shared paper, 2021 · strength 0.11
    • Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.